Yozo Suzuki
Overview
Explore the profile of Yozo Suzuki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
630
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fukuda K, Shimizu J, Matsushita K, Yamashita M, Noma T, Hagihara K, et al.
Gan To Kagaku Ryoho
. 2025 Mar;
52(2):176-178.
PMID: 40073900
The 1-year survival rate of patients with unresectable hepatocellular carcinoma is less than 50%, which indicates a poor prognosis. Recently, the combination of atezolizumab and bevacizumab has improved the prognosis...
2.
Suzuki Y, Ikenaga M, Hagihara K, Kusunoki Y, Matsushita K, Noma T, et al.
Gan To Kagaku Ryoho
. 2025 Feb;
51(13):1794-1796.
PMID: 39949002
A 60s-year-old male on continuous ambulatory peritoneal dialysis(CAPD)with a history of peritoneal infection and ischemic cardiac disease was referred to our hospital for the evaluation of a positive fecal occult...
3.
Iijima K, Suzuki Y, Hagihara K, Ikenaga M, Sato Y, Noma T, et al.
Gan To Kagaku Ryoho
. 2025 Feb;
51(13):1791-1793.
PMID: 39949001
An 89-year-old woman with an allergy to contrast dye and with a history of cholecystectomy visited emergency department complaining of vomiting and abdominal pain. The diagnosis of adhesive bowel obstruction...
4.
Yamashita M, Shimizu J, Matsushita K, Sato Y, Noma T, Hagihara K, et al.
Gan To Kagaku Ryoho
. 2025 Feb;
51(13):1721-1723.
PMID: 39948978
Introduction: Endoscopic ultrasonography guided fine needle aspiration(EUS-FNA)is an essential diagnostic method for qualitative diagnosis of pancreatic tumors and is widely used for the diagnosis of pancreatic cancer. However, there is...
5.
Hagihara K, Ikenaga M, Suzuki Y, Noma T, Matsushita K, Shinno N, et al.
Gan To Kagaku Ryoho
. 2025 Feb;
51(13):1408-1410.
PMID: 39948872
Three patients with locally advanced sigmoid colon cancer with bladder invasion underwent 8 courses of neoadjuvant chemotherapy to achieve complete resection and bladder preservation. All 3 patients showed tumor shrinkage...
6.
Matsushita K, Shimizu J, Yamashita M, Noma T, Hagihara K, Yanagimoto Y, et al.
Gan To Kagaku Ryoho
. 2025 Feb;
51(13):1348-1350.
PMID: 39948852
The patient presented with a 38 mm-sized mass in the S3/4 of the liver on contrast-enhanced CT in his seventies. He underwent hepatic left lobectomy and cholecystectomy as hepatocellular carcinoma....
7.
Miyo M, Uemura M, Ozato Y, Nishimura J, Nakata K, Suzuki Y, et al.
Surgery
. 2024 Nov;
178():108874.
PMID: 39516112
Aims: Whether rotation of a diverting loop ileostomy during rectal cancer surgery, for reducing the catastrophic effect of an anastomotic leakage, affects the incidence of small-bowel obstruction has not been...
8.
Hata T, Uemura M, Danno K, Yoshioka S, Matsuda C, Kagawa Y, et al.
Sci Rep
. 2024 Nov;
14(1):26434.
PMID: 39488510
Adjuvant oxaliplatin plus capecitabine (XELOX) therapy is recommended for patients with curatively resected colon cancer. However, prospective data on its practical application in Japanese patients are limited. Therefore, we aimed...
9.
Suzuki Y, Tei M, Wakasugi M, Ohtsuka M, Hagihara K, Ikenaga M, et al.
J Anus Rectum Colon
. 2024 May;
8(2):48-60.
PMID: 38689785
Although single-incision laparoscopic surgery (SILS) has gained some attention as a feasible alternative to conventional multiport laparoscopic surgery (MPLS) in colonic surgery, it became less prevalent than expected. Hence, we...
10.
Kawase T, Imamura H, Yanagimoto Y, Odagiri K, Suzuki Y, Takeyama H, et al.
Gan To Kagaku Ryoho
. 2024 Mar;
51(3):311-313.
PMID: 38494815
Background: According to the sixth Gastric Cancer Treatment Guideline, the regimen included nab-paclitaxel(nab-PTX) is a conditional recommendation as second-line treatment for advanced gastric cancer. However, the selection criteria of nab-PTX...